What does Ocean Biomedical, Inc. do?

Ocean Biomedical, Inc. is a public company in the Pharmaceutical Preparations industry, incorporated in DE. It is registered with the SEC under CIK 0001869974 and trades on OTC under the ticker OCEA.

Is Ocean Biomedical, Inc. profitable?

Ocean Biomedical, Inc. reported a net loss of $9.48M in FY2024. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Ocean Biomedical, Inc. made?

Ocean Biomedical, Inc. has filed 255 documents with the SEC since 2021. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Ocean Biomedical, Inc.

OCEA OTC CIK: 0001869974 Pharmaceutical Preparations Inc. in DE

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 255 filings →

Form	Description	Date
NT 10-Q	NT 10-Q	Aug 14, 2025
25-NSE	—	Aug 8, 2025
8-K	8-K	Aug 5, 2025
8-K	8-K	Jul 23, 2025
8-K	8-K	Jul 16, 2025
8-K	8-K	Jun 13, 2025
10-Q	10-Q	May 15, 2025
10-K/A	ANNUAL REPORT	Apr 29, 2025
8-K	—	Apr 23, 2025
10-K	—	Apr 8, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Ocean Biomedical, Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: ($9.48M) (FY2024)
Total Assets: $902.0K (FY2024)
Operating Income: ($3.80M)

Full financials →

Details

CIK: 0001869974
Ticker: OCEA
Exchange: OTC
Incorporated: DE
First Filing: 2021
Total Filings: 255

Pharmaceutical Preparations rankings →